Ipamorelin is an investigational growth hormone secretagogue that acts at the ghrelin receptor and is studied for its ability to stimulate growth hormone release.

POTENTIAL AREAS OF RESEARCH

• GROWTH HORMONE RELEASE – Studied for its ability to stimulate endogenous growth hormone secretion.

• BODY COMPOSITION – Research has explored growth-hormone-related pathways involved in lean body mass and body composition.

• SLEEP & RECOVERY – Growth hormone physiology is closely associated with sleep and recovery, although specific clinical benefits from ipamorelin have not been established.

• TISSUE & MUSCLE RESEARCH – Investigated in research involving growth-hormone signaling and its potential relationship to tissue and muscle physiology.

• METABOLIC FUNCTION – Researchers continue to study how growth hormone secretagogues may influence metabolic pathways and overall physiology.

IMPORTANT: Ipamorelin is not FDA-approved for medical treatment. Its safety and effectiveness in humans have not been established, and potential research effects should not be presented as proven therapeutic benefits.